Search

everythinglearnresearchcommunity

for

Search:↓

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

Low intensity ultrasound may reduce side effects of chemotherapy drugs like paclitaxel.

Nasal septum injury in rats changes behavior and affects the nervous system.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Better supportive care is needed to manage chemotherapy side effects.

Eclipta alba has many health benefits and contains compounds with potential for drug development.

Hair follicles can be used to quickly assess drug effects in cancer treatment.

EGFR is essential for organized skin nerve growth and branching.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Cannabis, cryotherapy, and scalp cooling can help improve the quality of life for chemotherapy patients.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.